Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Drew R DeBay

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|November 25, 2023
Combined PET/MR: Where Anatomical Imaging Meets Cellular FunctionDrew R DeBay, Kimberly D Brewer
EJNMMI Physics|June 1, 2023
NEMA NU 1-2018 performance characterization and Monte Carlo model validation of the Cubresa Spark SiPM-based preclinical SPECT scannerMatthew E Strugari, Drew R DeBay, Steven D Beyea, et al.
Scientific Reports|December 22, 2022
No difference in cerebral perfusion between the wild-type and the 5XFAD mouse model of Alzheimer's diseaseDrew R DeBay, Tân-Trào Phi, Chris V Bowen, et al.
Alzheimer'S & Dementia (New York, N. Y.)|October 26, 2017
Targeting butyrylcholinesterase for preclinical single photon emission computed tomography (SPECT) imaging of Alzheimer's diseaseDrew R DeBay, George A Reid, Ian R Pottie, et al.
Journal of Alzheimer'S Disease : JAD|April 29, 2017
Quantification of Butyrylcholinesterase Activity as a Sensitive and Specific Biomarker of Alzheimer's DiseaseIan R Macdonald, Selena P Maxwell, George A Reid, et al.
Molecular Imaging and Biology|May 28, 2026
Molecular Imaging of Butyrylcholinesterase Associated with Amyloid-β Plaques Distinguishes 5XFAD from Wild-Type Mice: A Proof-of-ConceptG Andrew Reid, Drew R DeBay, Ian R Macdonald, et al.
Brain Research|July 22, 2017
Butyrylcholinesterase-knockout reduces fibrillar β-amyloid and conserves <sup>18</sup>FDG retention in 5XFAD mouse model of Alzheimer's diseaseDrew R DeBay, George A Reid, Ian R Macdonald, et al.
Molecular Therapy. Methods & Clinical Development|January 6, 2016
Using MRI to evaluate and predict therapeutic success from depot-based cancer vaccinesDrew R DeBay, Kimberly D Brewer, Sarah A LeBlanc, et al.
Vaccine|December 3, 2014
Clearance of depot vaccine SPIO-labeled antigen and substrate visualized using MRIKimberly D Brewer, Kerry Lake, Nicole Pelot, et al.
Oncotarget|May 28, 2016
Using lymph node swelling as a potential biomarker for successful vaccinationKimberly D Brewer, Drew R DeBay, Iulia Dude, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Methods in Molecular Biology (Clifton, N.J.)|November 25, 2023
Combined PET/MR: Where Anatomical Imaging Meets Cellular FunctionDrew R DeBay, Kimberly D Brewer
EJNMMI Physics|June 1, 2023
NEMA NU 1-2018 performance characterization and Monte Carlo model validation of the Cubresa Spark SiPM-based preclinical SPECT scannerMatthew E Strugari, Drew R DeBay, Steven D Beyea, et al.
Scientific Reports|December 22, 2022
No difference in cerebral perfusion between the wild-type and the 5XFAD mouse model of Alzheimer's diseaseDrew R DeBay, Tân-Trào Phi, Chris V Bowen, et al.
Alzheimer'S & Dementia (New York, N. Y.)|October 26, 2017
Targeting butyrylcholinesterase for preclinical single photon emission computed tomography (SPECT) imaging of Alzheimer's diseaseDrew R DeBay, George A Reid, Ian R Pottie, et al.
Journal of Alzheimer'S Disease : JAD|April 29, 2017
Quantification of Butyrylcholinesterase Activity as a Sensitive and Specific Biomarker of Alzheimer's DiseaseIan R Macdonald, Selena P Maxwell, George A Reid, et al.
Molecular Imaging and Biology|May 28, 2026
Molecular Imaging of Butyrylcholinesterase Associated with Amyloid-β Plaques Distinguishes 5XFAD from Wild-Type Mice: A Proof-of-ConceptG Andrew Reid, Drew R DeBay, Ian R Macdonald, et al.
Brain Research|July 22, 2017
Butyrylcholinesterase-knockout reduces fibrillar β-amyloid and conserves <sup>18</sup>FDG retention in 5XFAD mouse model of Alzheimer's diseaseDrew R DeBay, George A Reid, Ian R Macdonald, et al.
Molecular Therapy. Methods & Clinical Development|January 6, 2016
Using MRI to evaluate and predict therapeutic success from depot-based cancer vaccinesDrew R DeBay, Kimberly D Brewer, Sarah A LeBlanc, et al.
Vaccine|December 3, 2014
Clearance of depot vaccine SPIO-labeled antigen and substrate visualized using MRIKimberly D Brewer, Kerry Lake, Nicole Pelot, et al.
Oncotarget|May 28, 2016
Using lymph node swelling as a potential biomarker for successful vaccinationKimberly D Brewer, Drew R DeBay, Iulia Dude, et al.
Pageof 1